Over Half of Cannabis Users with Parkinson s Disease Report Clinical Benefits
A survey in Germany found more than eight percent of patients with Parkinson s disease are using cannabis products and more than half experienced beneficial clinical effects
January 28, 2021
AMSTERDAM, THE NETHERLANDS January 26, 2021 With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson s disease (PD). According to results of a survey of PD patients in Germany in the
, over eight of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect.
E-Mail
Amsterdam, NL, January 26, 2021 - With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use to alleviate symptoms of many illnesses including Parkinson s disease (PD). According to results of a survey of PD patients in Germany in the
Journal of Parkinson s Disease, over 8% of patients with PD reported using cannabis products and more than half of those users (54%) reported a beneficial clinical effect.
Cannabis products containing THC (tetrahydrocannabinol, the main psychoactive compound of cannabis) can be prescribed in Germany when previous therapies are unsuccessful or not tolerated, and where cannabis can be expected with not a very unlikely chance to relieve disabling symptoms. CBD (pure cannabidiol, derived directly from the hemp plant, a cousin of the marijuana plant) is available without a prescription from pharmacies and on the internet.